Rump J A, Jahreis A, Schlesier M, Dräger R, Melchers I, Peter H H
Department of Rheumatology and Clinical Immunology, University of Freiburg, Germany.
Clin Exp Immunol. 1992 Aug;89(2):204-10. doi: 10.1111/j.1365-2249.1992.tb06933.x.
Common variable immunodeficiency (CVID) patients are unable to produce specific immunoglobulins after antigen contact in vivo. The aim of this study was to investigate whether in some cases of CVID a decreased de novo synthesis of IL-2 might be the cause of immunodeficiency and whether this deficiency can be corrected by IL-2 supplementation in vitro. Mononuclear cells from 17 CVID patients and from 10 healthy controls were cultured with monoclonal anti-CD3 antibody OKT3, pokeweed mitogen (PWM) or tetanus toxoid (TT) to stimulate IL-2 synthesis. In parallel, in vitro IgG and IgM synthesis was stimulated with Staphylococcus aureus Cowan I (SAC), PWM or TT in the presence or absence of IL-2. While lymphocytes of 11 out of 17 patients produced low to normal amounts of IL-2 upon stimulation with anti-CD3, only three patients showed low IL-2 production in response to PWM and five in response to TT. Regarding immunoglobulin synthesis in vitro, five patients completely failed to produce IgM or IgG upon stimulation with PWM, SAC or TT irrespective of the addition of IL-2. By contrast, four patients did not show any defect in vitro and synthesized normal amounts of IgM and IgG with any of the three stimuli. Finally, eight patients could be reconstituted for PWM-, SAC- and TT-induced IgM and/or IgG synthesis in vitro, by adding IL-2 to the culture system. This enhancing effect of IL-2 could be blocked by adding anti-IL-2 receptor antibodies to the cultures. Our findings indicate that a defective IL-2 synthesis after antigen stimulation may be one reason for the impaired immunoglobulin production in some cases of CVID.
常见可变免疫缺陷(CVID)患者在体内抗原接触后无法产生特异性免疫球蛋白。本研究的目的是调查在某些CVID病例中,IL-2从头合成减少是否可能是免疫缺陷的原因,以及这种缺陷是否可以通过体外补充IL-2来纠正。将17例CVID患者和10例健康对照的单核细胞与单克隆抗CD3抗体OKT3、商陆有丝分裂原(PWM)或破伤风类毒素(TT)一起培养,以刺激IL-2合成。同时,在有或没有IL-2的情况下,用金黄色葡萄球菌Cowan I(SAC)、PWM或TT刺激体外IgG和IgM合成。虽然17例患者中有11例的淋巴细胞在用抗CD3刺激后产生的IL-2量低至正常,但只有3例患者对PWM刺激显示IL-2产生低,5例对TT刺激显示IL-2产生低。关于体外免疫球蛋白合成,5例患者在用PWM、SAC或TT刺激时,无论是否添加IL-2,都完全无法产生IgM或IgG。相比之下,4例患者在体外没有显示任何缺陷,并且在三种刺激中的任何一种刺激下都合成了正常量的IgM和IgG。最后,通过向培养系统中添加IL-2,可以使8例患者在体外重建PWM、SAC和TT诱导的IgM和/或IgG合成。向培养物中添加抗IL-2受体抗体可阻断IL-2的这种增强作用。我们的研究结果表明,抗原刺激后IL-2合成缺陷可能是某些CVID病例中免疫球蛋白产生受损的一个原因。